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Abstract
The United States is experiencing an epidemic of chronic disease.
As  the  US  population  ages,  health  care  providers  and  policy
makers urgently need decision models that provide systematic,
credible  prediction  regarding  the  prevention  and  treatment  of
chronic diseases to improve population health management and
medical decision-making. Agent-based modeling is a promising
systems science approach that can model complex interactions and
processes related to chronic health conditions, such as adaptive be-
haviors, feedback loops, and contextual effects. This article intro-
duces agent-based modeling by providing a narrative review of
agent-based models of chronic disease and identifying the charac-
teristics of various chronic health conditions that must be taken in-
to account to build effective clinical- and policy-relevant models.
We also identify barriers to adopting agent-based models to study
chronic diseases. Finally, we discuss future research directions of
agent-based  modeling  applied  to  problems  related  to  specific
chronic health conditions.
Introduction
Americans are facing a growing burden of chronic disease that in-
cludes heart disease, stroke, diabetes, and obesity. By 2013, nearly
half of the adult population in the United States had at least one
chronic health condition, and approximately 70% of deaths were
caused by chronic disease (1). The high prevalence of chronic dis-
ease is also a substantial economic burden to the nation. A 2007
report from the Milken Institute estimated that the total impact of
chronic disease on the US economy was $1.3 trillion annually (2).
As the retirement-aged population in the United States continues
its rapid growth, health care providers and policy makers need to
make informed decisions to effectively control the chronic disease
epidemic  and,  thereby,  improve population  health  and reduce
health care costs.
Systems science methodologies such as system dynamics, dis-
crete-event simulation, network analysis, and agent-based model-
ing have the potential to inform decision makers on how chronic
health conditions develop and their consequences. Unlike stand-
ard statistical models, which often assume independence of obser-
vations, unidirectional causality, and noninterference, systems sci-
ence methodologies allow for integration of data and evidence
from many different sources and at many levels of analysis (3).
However, compared with mainstream statistical methodologies
and experimental studies, systems science methodologies are un-
derused  during  the  development  of  health  policy,  population
health management, and clinical decision-making (3,4).
This article 1) introduces the concept of agent-based modeling —
a relatively new systems science methodology, 2) reviews exist-
ing agent-based modeling of several prevalent chronic diseases (ie,
diabetes, cardiovascular disease, obesity), 3) identifies barriers to
adopting agent-based modeling to study chronic diseases, and 4)
proposes novel research directions in this promising field that can
lead to informed policy and practice.
Agent-Based Modeling
Agent-based modeling is a computational modeling approach in
which system-level emergent phenomena can be observed through
explicit modeling of individual behaviors and their interactions
with each other and with the environment (5,6). Agents (eg, indi-
viduals, organizations) in an agent-based model may be endowed
with a large set of “real-world” properties (Table). Agent-based
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models can be used to uncover complex causal effects, identify
underlying mechanisms behind complex systems, and make sense
of large amounts of existing evidence and data. In addition, the
fast growth of agent-based modeling software, such as NetLogo
(The Center for Connected Learning and Computer-Based Model-
ing, Northwestern University), Repast (Argonne National Laborat-
ory), Swarm (Swarm Development Group), and AnyLogic (The
AnyLogic Company), has simplified the model development pro-
cess and facilitated the use of agent-based modeling in various
fields.
In medicine and public health, state-transition models (eg, Markov
models) have been widely used to capture disease progression and
inform medical decision-making and public health intervention
design (7). Markov models assume that the probability distribu-
tion of future states depends only on the present state and, thus,
cannot reflect the fact that risk factors developed early in life af-
fect future disease progression. Moreover, these models have sig-
nificant limitations when risk factors and outcomes of the disease
being studied exhibit complex properties such as adaptive behavi-
ors (ie, people can change behaviors on the basis of the current
state of the system), feedback loops (ie, causal effects can be rein-
forced or offset over time), and contextual effects (ie, individual
health factors and outcomes are affected by social, cultural, and
economic factors) (8,9). Agent-based modeling can integrate these
complex properties and help elucidate interdependent causal ef-
fects  and the impact  of  these interdependencies on population
health (9–11).
Agent-based modeling also represents a promising approach to
conducting counterfactual studies (9). In most observational stud-
ies, the analytical focus centers on a single intervention or expos-
ure. A robust analysis of causal effects focuses on knowing what
would have happened if a given intervention had not been imple-
mented or if a different intervention had been implemented. In
agent-based modeling, agents can represent people who 1) have
heterogeneous demographic characteristics (eg, age, sex, race/eth-
nicity) and behaviors (eg, smoking, having an unhealthful diet), 2)
exhibit endogenous evolution of health conditions (eg, having el-
evated blood pressure, developing type 2 diabetes) and exogenous
interactions (eg, transmission of infectious disease, diffusion of
health information), and 3) live in a certain geographic location or
participate in a virtual social environment (eg, Facebook). By us-
ing agent-based modeling, investigators can predict counterfactual
outcomes of any intervention or no intervention on the same popu-
lation in the same physical and social environment. The simulated
results enable researchers to identify causal effects between risk
factors and health outcomes and compare the effectiveness of in-
terventions.
Agent-based modeling applications are much more common in the
study of infectious diseases (eg, influenza, sexually transmitted
diseases) than chronic diseases (12). One reason is that infectious
diseases have a clear path of disease transmission characterized by
nonlinear, stochastic, and dynamic interactions between human
beings and the environment. These interactive and complex fea-
tures cannot be captured with traditional statistical models or mod-
els based on differential equations (13). By generating popula-
tions of different sizes and incorporating geographic location in-
formation, agent-based modeling provides the flexibility to model
disease transmissions at different scales from local to global and to
examine the impact of alternative interventions. For example, Lee
et al developed an agent-based model of the H1N1 influenza to
design vaccination allocation strategies (14).
In addition to modeling infectious diseases, agent-based modeling
has been used to assess different strategies designed to combat ad-
dictive behaviors such as alcohol use and smoking (15,16). It is
worth noting that the US Food and Drug Administration, working
with the Institute of Medicine, has explored agent-based modeling
as a way to inform its policy decisions on tobacco control (11).
Because smoking is a major risk factor for many chronic diseases,
developing agent-based models of chronic disease may be a natur-
al next step. However, such models are still rare.
Nianogo et al recently conducted a systematic review of agent-
based modeling of noncommunicable diseases and underscored
the importance of using agent-based modeling to inform design of
public health interventions (17). However, 14 out of the 22 stud-
ies those authors reviewed modeled only health behaviors (eg,
walking, alcohol use, diet, smoking) and not chronic disease pro-
gression. With a focus on specific chronic diseases (ie, diabetes,
cardiovascular disease, obesity), we searched PubMed (Medline)
by  using a combination of keywords from 2 categories: 1) agent-
based model or individual-based model, and 2) heart disease, car-
diovascular disease, diabetes, or obesity. We did not conduct a
systematic review, because the body of evidence was too sparse
after  we  excluded  models  of  behaviors.  Another  difference
between this study and that of Nianogo et al is that we compare
agent-based modeling with other modeling approaches in general
and point out future research directions with regard to specific
chronic diseases (17).
Examples of Agent-Based Models of
Chronic Diseases
Diabetes
Diabetes is a metabolic disease caused by the interplay among
many exogenous and endogenous factors (eg, lifestyle, genes, en-
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vironment) that leads to complications and adverse health out-
comes (eg, retinopathy, neuropathy, nephropathy, myocardial in-
farction, stroke, death). The prevalence of diabetes in the United
States is projected to increase from 9.3% in 2012 to 33% by 2050
(18). In addition, diabetes costs the country approximately $245
billion per year (19). Both Markov-based models and system dy-
namics models have been developed to study the progression of
diabetes and its  complications and the impact of interventions
(20,21).
Day et al provided an example of studying diabetes with agent-
based modeling (22). In particular, they developed an agent-based
modeling template for diabetic retinopathy, a common diabetes-re-
lated complication and the leading cause of blindness among US
adults. Agents in their model are heterogeneous patients with a
range of attributes — age, sex, smoking status, body mass index
(BMI), HemoglobinA1c (glycated hemoglobin) level, duration of
diabetes, hypertension, high cholesterol, diabetic nephropathy, and
current status of nonproliferative diabetic retinopathy and prolifer-
ative diabetic retinopathy. They used longitudinal patient data
(from 2006–2010) extracted from the eye clinic of the Veterans
Administration St. Louis Healthcare System to calibrate model
parameters and conduct predictive validation. They used agent-
based modeling to assess the impact of different screening inter-
vals on the incidence of vision loss among a simulated cohort of
veterans and found that a screening interval of 2 years was the
most reasonable and should be adopted (23).
Cardiovascular disease
Cardiovascular disease is the leading cause of death in the United
States (24). The total direct medical cost of cardiovascular disease
is projected to increase from $273 billion in 2010 to $818 billion
in 2030 (24). Unal et al conducted a systematic literature review of
coronary heart disease policy models and found all the models
were Markov models (25). Hirsch et al developed a system dy-
namics model for cardiovascular disease and used the model to
evaluate the effectiveness of various interventions (26). However,
their model was unable to capture the impact of heterogeneous
populations on the effectiveness of different interventions, limit-
ing the generalizability of the findings to other populations.
To overcome the limitations associated with Markov models and
system dynamics models when assessing cardiovascular disease
progression, Li et al developed an agent-based model of cardi-
ovascular disease and used the model to evaluate the impact of
several  lifestyle  interventions  —quitting  smoking,  increasing
physical activity, promoting healthy diet, and reducing weight —
on the long-term prevalence and incidence of myocardial infarc-
tion and stroke for populations across different age groups or geo-
graphic locations (27,28). In their model, each agent (person) was
defined  according  to  7  key  behaviors  or  health  factors  (ie,
smoking, physical activity, diet, weight, cholesterol, blood pres-
sure, and blood glucose) and by age, sex, and whether the person
had a history of myocardial infarction or stroke. These factors
were selected on the basis of the concept of ideal cardiovascular
health developed by the American Heart Association (29). Each
agent’s behaviors and health factors evolve simultaneously and in-
teractively as time progresses in the model. The model was valid-
ated by using data from the 2007 Behavioral Risk Factor Surveil-
lance  System  (ht tp: / /www.cdc.gov/brfss/annual_data/
annual_2007.htm) and the 2012 Behavioral Risk Factor Surveil-
lance  System  (ht tp: / /www.cdc.gov/brfss/annual_data/
annual_2012.html). The authors showed that a prevention inter-
vention may have different effects on populations in different geo-
graphical areas; for example, a hypothetical lifestyle intervention
promoting healthful diet, physical activity, and smoking cessation
may reduce the proportion of the population with diabetes more
significantly in the Buffalo-Cheektowaga-Tonawanda Metropolit-
an Statistical Area than it would in New York City (27). Thus, loc-
al health departments need to take into account their population
characteristics and health profiles when prioritizing prevention in-
terventions.
Obesity
Obesity, defined as a body mass index (BMI) (kg/m2) of 30 or
greater, is a chronic condition and also an important risk factor for
many other chronic diseases, including hypertension, hypercholes-
terolemia,  type 2 diabetes,  asthma,  myocardial  infarction,  and
stroke. The prevalence of obesity among US adults increased sig-
nificantly from 2000 through 2010 and reached about 36.5% from
2011 through 2014 (30). The annual direct medical costs associ-
ated with overweight and obesity in 2008 was estimated to be
nearly $114 billion, which accounted for approximately 5% to
10% of US health care spending (31). The change in a person’s
BMI is a complex process characterized by interactions among
multiple biologic, behavioral, socio-economic, environmental, and
cultural factors. Levy et al provided a detailed review of 14 simu-
lation models of obesity (32).
Hammond and Ornstein developed an agent-based model to expli-
citly capture the impact of social influence on body weight (33). In
their model, social influence changes each individual’s BMI on the
basis of the theory of “follow the average” (34). The authors valid-
ated their simulation results by using data from a longitudinal sur-
vey  of  American  youth  (ie,  National  Longitudinal  Survey  of
Youth  1997  cohort  [https://www.nlsinfo.org/content/cohorts/
nlsy97]). Similarly, Zhang et al developed an agent-based model
to examine the impact  of  social  influence on adolescent  over-
weight and obesity (35). They compared 5 adolescent social net-
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work-related interventions and found that strengthening peer influ-
ence may be effective to combat obesity in populations with low
obesity prevalence. Finally, El-Sayed et al built an agent-based so-
cial network model of obesity for the population of England to
study  the  effectiveness  of  interventions  targeting  highly  net-
worked individuals (36). By using data from the Health Surveys
for England in 1999 and 2004 (https://www.ucl.ac.uk/hssrg/stud-
ies/hse), they found that interventions targeting highly networked
individuals were no more likely to reduce obesity prevalence than
were interventions targeting random populations.
Future Research Directions
Research using agent-based modeling to study chronic diseases is
still in its infancy. We provided 3 possible reasons for a low adop-
tion rate of agent-based modeling in the study of chronic health
conditions and their consequences. First, chronic diseases are not
characterized by clear “transmission” mechanisms; thus, many re-
searchers  are  reluctant  to  use  agent-based  modeling  to  study
chronic diseases because of the general  perception that  agent-
based modeling is only suitable to model health conditions that
can be transmitted from person to person. Second, it is generally
more  difficult  to  implement  agent-based  modeling  than  more
widely used simulation approaches such as Markov-based state-
transition models. In most cases, developing an agent-based mod-
el requires some training in computer programming, whereas con-
structing Markov-based models can be done using spreadsheet
software (eg, Microsoft Excel) or specialized, easy-to-use soft-
ware such as TreeAge Pro (TreeAge Software, Inc). Finally, the
development of agent-based models generally requires a large
amount of individual-level data for parameterization, calibration,
and validation; such data are not always available to researchers.
Despite these barriers, we believe that policymakers and health
care providers would benefit from having access to high-quality,
well-designed agent-based models that can help them better under-
stand the development and consequences of chronic diseases and
thereby improve their decision-making with regard to intervention
design and resource allocation.
Disease-specific future research directions
Diabetes. To the best of our knowledge, agent-based modeling has
only been applied to the study of diabetic retinopathy (22,23).
However, we believe that it can also be useful to study the pro-
gression of other diabetic complications — nephropathy, neuro-
pathy, myocardial infarction, and stroke. In addition, future agent-
based models should incorporate health behaviors, such as diet,
physical activity, and smoking, and examine the impact of modify-
ing behaviors on the prevention and management of diabetes. Fi-
nally, agent-based modeling should take into account the impact
of comorbidities (eg, obesity, hypertension, hyperlipidemia) and
pharmacologic interventions on the health outcomes of a person
with diabetes.
Cardiovascular disease. Although the model in the study by Li et
al demonstrated the possibility of using an agent-based model to
study cardiovascular disease, the model has some limitations re-
lated to its design and structure (27). For example, a person is
either of normal weight or overweight in the model, and detailed
changes in BMI are not modeled. We believe that an agent-based
model of cardiovascular disease with more detailed disease pro-
gression and validated model prediction will  provide potential
users with more precise insights and more confidence in using the
results to inform decision-making. In addition, we suggest incor-
porating social influence in future modeling when studying the im-
pact of lifestyle interventions on cardiovascular disease. Finally,
future agent-based models of cardiovascular disease could take in-
to account the effects of different treatment strategies, drug ther-
apies, and procedures (eg, revascularization, pacemaker implanta-
tion) to improve their clinical relevance.
Obesity. Most agent-based models of obesity focused on the im-
pact of social influences (peer effects) on the dynamics of obesity
(33,35). However, social influences may not be the only factors or
the most important factors associated with obesity. We suggest in-
corporating health behaviors, such as physical activity and diet, in
future  agent-based  models  of  obesity.  Moreover,  agent-based
models of obesity could be more useful if they took into account
evidence from biology, behavioral science, and psychology to bet-
ter understand the development and progression of obesity.
Multimorbidity. Although multimorbidity has become the most
common chronic condition among the elderly population (age 65
or older) in the United States (37), credible agent-based models
studying the development and consequences of multimorbidity are
lacking. Thus, modelers and interested public health and medical
researchers should strive to develop comprehensive agent-based
models of multimorbidity in which both the characteristics of indi-
vidual  chronic  conditions  as  well  as  the  possible  interactions
across these health conditions are explicitly captured.
Purpose-specific future research directions
Risk assessment. Risk assessment for chronic disease is an essen-
tial component of population health management. Current risk as-
sessment tools rely on standard statistical models (eg, regression)
to identify correlations in somewhat limited administrative data
sets. Even more advanced statistical methods, such as structural
equation modeling and latent class analysis, are unable to capture
the common nonlinearity, interdependency, and dynamics of risk
factors and disease outcomes among the individuals that make up
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a population. Thus, a promising future research direction is to use
agent-based models to assess the risk of chronic disease and dis-
ease-specific mortality. Agent-based models capture the develop-
ment  of  chronic  disease  as  an  emergent  outcome  of  a  set  of
factors, including health beliefs, social norms, lifestyle behaviors,
medication  compliance,  and  biomarkers,  that  often  change
stochastically, dynamically, and interactively. As demonstrated in
Li et al, an agent-based model of cardiovascular disease can be
used to assess the risk of a population of interest and, potentially,
can become an essential part of population health management
(28).
Cost-effectiveness analysis. Most model-based cost-effectiveness
analyses are based on Markov models. However, Markov models
have been criticized for having many limitations and inherent as-
sumptions that may render the results misleading (38). Examples
of limitations for Markov models are its inability to model hetero-
geneous populations (ie, with a set of population characteristics)
or to account for dependence on prior states of the system. A few
studies have demonstrated that agent-based modeling can over-
come some limitations of Markov models and provide decision-
makers with more flexibility in studying the cost-effectiveness of a
certain intervention to prevent chronic diseases (39,40). However,
researchers have not fully taken advantage of the modeling power
of agent-based models — such as capturing population interac-
tions and integrating individual-level data — to improve the accur-
acy and credibility of cost-effectiveness analysis.
Although agent-based modeling is a powerful approach to study-
ing chronic health conditions, it remains an underused tool among
researchers in medicine and public health who are interested in
chronic  disease  prevention  and  management.  We provide  ex-
amples of agent-based modeling applications in the areas of dia-
betes,  cardiovascular  disease,  and obesity.  The broader use of
agent-based modeling has the potential to provide new insights in
the areas of population health management, medical decision-mak-
ing, and health care policy formulation and assessment.
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Table
Table. Key Properties of Agent-Based Modeling of Chronic Diseases
Property Description
Interactive Agents can interact with each other or with the environment
Heterogeneous Agents can have different attributes, states, or behaviors
Dynamic Agents can change their attributes, states, or behaviors with time or location
Stochastic Agents can decide their attributes, states, or behaviors based on probability distribution
Rational Agents can act in their best interest based on their own knowledge and preference
Adaptive Agents can change their states or behaviors based on the current state of the system
Autonomous Agents can decide their own states or behaviors
Mobile Agents can move in a geographic space
Memory Agents can remember their previous attributes, states, and behaviors or the history of the system
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